Jim Cramer Weighs In On CVS, Starbucks, Tilray And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said Starbucks Corporation SBUX is doing well. The stock traded higher on Tuesday, which is a sign of great strength.

Penumbra Inc PEN is a medical device company, but Cramer is not that familiar with it. He added that he likes DexCom, Inc. DXCM.

Healthequity Inc HQY is a very interesting company and it can be much bigger than it really is, said Cramer. He really likes it.

Cramer can't recommend Turning Point Brands Inc TPB because it's a tobacco stock.

Instead of Tilray Inc TLRY, Cramer would buy Canopy Growth Corp CGC. He explained that Tilray's ownership structure is messed up.

CVS Health Corp CVS is a bargain at its current price level, believes Cramer. He thinks the last quarter was good.

Timken Co TKR represents the best of American manufacturing, said Cramer.